Return to CBI Antibody Core Home Page
  Return to human list
    Return to human ( Homo sapiens ) list


human ( Homo sapiens )
p153



Western result: +
GST
GST-p153
(fragment)

38 kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (GST-antigen fusion protein). The negative control lane is the same except it contains ~50ng to 100 ng of a GST fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used and it is fused to GST.

Antibody Name/Abbreviation: p153
CBI Antibody Core Code: A0937

"Lot" Number: 1 Position: 100 (132-231)
% Identical Homology of Target to Mouse Protein: 51% (NP_796268.2| RNA polymerase II associated protein 1)
Molecular Weight of fusion protein: 38 KDa

Target sequence used to make this antibody:
VFLRSRDTQGKSATSGKRSIFAQEIAARRIAEAKGPSVGE
VVPNVGPPEGAVTCETPTPRNQGCQLPGSSHSFQGPNLVT
GKGLRDQEAEQEAQTIHEEN






Sequence Name: p153
Full name: DKFZP727M111
UniGene Number: N.A.
Accession Number: NP_056355
Source organism: human ( Homo sapiens )
Full length size (aa): 1393
NCBI information page:

Full length sequence:
mlsrpkpgesevdllhfqsqflaagaapavqlvkkgnrgggdansdrppl
qdhrdvvmldnlpdlppalvpsppkrarpspghclpededpeerlrrhdq
hitavltkiierdtssvavnlpvpsgvafpavflrsrdtqgksatsgkrs
ifaqeiaarriaeakgpsvgevvpnvgppegavtcetptprnqgcqlpgs
shsfqgpnlvtgkglrdqeaeqeaqtiheeniarlqamapeeilqeqqrl
laqldpslvaflrshshtqeqtgetaseeqrpggpsanvtkeeplmsafa
seprkrdklepeapalalpvtpqkewlhmdtveleklhwtqdlppvrrqq
tqermqarfslqgellapdvdlpthlglhhhgeeaeragyslqelfhltr
sqvsqqralalhvlaqvisraqagefgdrlagsvlsllldagflfllrfs
lddrvdgviatairalrallvapgdeelldstfswyhgaltfplmpsqed
kedededeecpagkakrkspeeesrpppdlarhdvikgllatsllprlry
vlevtypgpavvldilavlirlarhslesatrvlecprlietivreflpt
swspvgagptpslykvpcatamkllrvlasagrniaarllssfdlrsrlc
riiaeapqelalppeeaemlstealrlwavaasygqggylyrelypvlmr
alqvvprelsthppqplsmqriaslltlltqltlaagstpaetisdsaea
slsatpslvtwtqvsglqplvepclrqtlkllsrpemwravgpvpvacll
flgayyqawsqqpsscpedwlqdmqrlseelllpllsqptlgslwdslrh
csllcnplscvpaleappslvslgcsggcprlslagsaspfpfltallsl
lntlaqihkglcgqlaailaapglqnyflqcvapgaaphltpfsawalrh
eyhlqylalalaqkaaalqplpathaalyhgmalallsrllpgseylthe
lllscvfrleflpertsggpeaadfsdqlslgssrvprcgqgtllaqacq
dlpsirncylthcsparasllasqalhrgelqrvptlllpmptepllptd
wpflplirlyhrasdtpsglsptdtmgtamrvlqwvlvleswrpqalwav
ppaarlarlmcvflvdselfrespvqhlvaallaqlcqpqvlpnlnldcr
lpgltsfpdlyanfldhfeavsfgdhlfgalvllplqrrfsvtlrlalfg
ehvgalralslpltqlpvslecytvppednlallqlyfrtlvtgalrprw
cpvlyavavahvnsfifsqdpqssdevkaarrsmlqktwlladeglrqhl
lhyklpnstlpegfelysqlpplrqhylqrltstvlqngvset





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.